Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Alit Biotech (Shanghai) Co. Ltd. currently has 3 pending office actions within the Chemistry & Materials technology area. These matters are distributed among 3 distinct examiners and 3 distinct art units. This distribution indicates that each of the 3 pending office actions is being reviewed in a different art unit by a different examiner.
The busiest examiner for the company is NGUYEN, BOI-LIEN THI, who is responsible for 1 pending office action. Since there are 3 pending office actions and 3 distinct examiners, the workload is spread across the assigned personnel. The presence of 3 distinct art units within Chemistry & Materials shows that the company's applications span multiple specialized technical groups.
For patent practitioners, the 3 pending office actions require managing relationships with 3 distinct examiners. Because each action is in one of 3 distinct art units, the prosecution strategy may need to account for different internal practices. NGUYEN, BOI-LIEN THI, as the busiest examiner with 1 pending office action, represents a portion of the company's current active docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEISNER, WILLIAM H | 1 | 61.9% | +29.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18593905 | STIRRING DEVICES FOR BIOREACTORS | BEISNER, WILLIAM H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18593905 | STIRRING DEVICES FOR BIOREACTORS | BEISNER, WILLIAM H | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18593905 | STIRRING DEVICES FOR BIOREACTORS | BEISNER, WILLIAM H | 1799 | §102§112 | Non-Final OA | — | Pending | Mar 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlit Biotech (Shanghai) Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William H Beisner has the most, with 1 of Alit Biotech (Shanghai) Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
